Thrombosis of a drug-eluting stent after almost 2 years in an HIV-infected patient [5]

AIDS

Volumn 21, Issue 8, 2007, Pages 1064-1066

  Stöllberger, Claudia ^a   Armbruster, Christine ^b   Gmeinhart, Bernd ^c   Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b 2nd Medical Department   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EFAVIRENZ; LAMIVUDINE; PACLITAXEL; PRAVASTATIN; STAVUDINE; TENOFOVIR;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD CELL COUNT; BLOOD PRESSURE; BLOOD TRANSFUSION; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; THROMBOSIS; VIRUS LOAD;

HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOSIS;

EID: 34247561186     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280f6ceb9     Document Type: Letter

References (10)

1. Ong ATL, McFadden EP, Regar E, de Jaegere PPT, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45:2088-2092.
2. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108:1701-1706.
3. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
4. Matetzky S, Domingo M, Kar S, Noc M, Shah P, Kaul S, et al. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med 2003; 163:457-460.
5. Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, et al. Endothelial function in HIV-infected persons. Clin Infect Dis 2006; 42:1325-1332.
6. Shankar SS, Dube MP. Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents. Cardiovasc Toxicol 2004; 4:261-269.
7. Ray PE, Soler-Garcia AA, Xu L, Soderland C, Blumenthal R, Puri A. Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanism. Pediatr Nephrol 2005; 20:1401-1409.
8. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monteforte A, El-Sadr WM, Reiss P, et al., Data Collection on adverse Events of Anti-HIV-Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2003.
9. Armbruster C, Vorbach H, Steindl F, El Menyawi I. Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells. J Antimicrob Chemother 2001; 47:487-490.
10. Santos JL, Cruz I, Herrero FM, Albarrán C, González Matas JM, Luengo CM. Recurrent coronary thrombosis, factor V Leiden, primary antiphospholipid syndrome, and HIV. Rev Esp Cardiol 2004; 57:997-999.